Table 1.
Taxon | Species | Antigen/target/systemic host defense response | What is CRP doing? | Ref. | |
---|---|---|---|---|---|
Arthropods | Horseshoe crab (Limulus polyphemus) | Chemicals | Mercury (Hg) | Scavenger | 5 |
Molluscs | Giant African land snail (Achatina fulica) | Lead (Pb) | Reversion of the toxic effects | 6 | |
Teleosts | Rohu carp (Labeo rohita) | Cadmium (Cd), mercury (Hg), phenol, hexachlorocyclohexane | Elevated serum levels | 7, 8 | |
Major South Asian carp (Catla catla) | Cadmium (Cd), mercury (Hg), phenol, hexachlorocyclohexane | Elevated serum levels of glyco- sylated molecular variants | 9, 10 | ||
Channel catfish (Ictalurus punctatus) | Turpentine oil | Acute phase pattern | 11 | ||
Rainbow trout (Oncorhynchus mykiss) | Turpentine oil | Significant decreases in the expression | 12 | ||
Formalin, metriphonate or potassium permanganate | Up and down of serum levels | 13 | |||
Plaice (Pleuronectes platessa) | Acute phase response | Adrenal hormons | Elevated serum levels | 2 | |
Rainbow trout (Salmo gairdneri) | Temperature shock | Elevated serum levels | 14 | ||
Tongue sole (Cynoglossus semilaevis) | Bacteria and viruses, fungi, protists and metazoan parasites | Gram-negative pathogens (Edwardsiella tarda, Vibrio/Listonella anguillarum, Escherichia coli) Gram-positive pathogens (Streptococcus iniae) | Increasing respiratory burst and phagocytic capacity of peripheral blood leukocytes | 15 | |
Common carp (Cyprinus carpio) | Aeromonas spec. Escherichia coli | Elevated serum levels | 16, 17 | ||
Black rockfish (Sebastes schlegelii) | Polysaccharides or live Streptococcus iniae | Significant upregulation in spleen and head kidney tissues | 18 | ||
Rainbow trout (Salmo gairdneri) | Vibrio anguillarum (intraperitoneal challenge) | Significant increase of the opsonising effect of CRP on macrophage phagocytosis | 19 | ||
Ayu (Plecoglossus altivelis) | Vibrio anguillarum | Significant upregulation, inhibition of complement 3 deposition on the bacteria further inhibiting comple- ment-mediated opsonophagocyto- sis by monocytes/macrophages | 20 | ||
Zebrafish (Danio rerio) | Spring viremia carp virus (SVCV) | Neutralization of viral infectivity | 21 | ||
Common carp (Cyprinus carpio) | Cyprinid herpesvirus 3 (CyHV-3) | Significant increase of CRP levels, distinct organ- and time-dependent expression profile patterns | 22 | ||
Goldfish (Carassius auratus) | Trypanosoma carassii | High expression in the kidney, liver and spleen at various days post infection, enhanced complement-mediated killing of trypanosomes in vitro | 23 | ||
Mammals | Sprague Dawley rats | Chemicals | Raised level indicating acute tissue damage due to inflammation and necrosis caused by cadmium (Cd) | 24 | |
sequestration and excretion of mercury (Hg) | 25 | ||||
New Zealand white rabbits | Acute phase response | Typhoid vaccine | Accumulation at tissue sites of inflammation and necrosis | 26 | |
Transgenic mice expressing rabbit CRP | Endotoxemia | Confers resistance | 27 | ||
Antigen-induced arthritis | onfers resistance | 28 | |||
Beagle dogs | Surgery | Increased and rapidly decreased with convalescence | 29 | ||
Human | Severe trauma | Production of anti-inflammatory cytokines by CD14(high)CD16(+) monocytes | 30 | ||
Rat, human | Bacteria and viruses, fungi, protists and metazoan parasites | Plasmodium yoelii | Inhibits in vitro development in hepatocytes | 31 | |
Mouse | Staphylococcus aureus | Opsonine, involved in nonspecific resistance | 32 | ||
CRP transgenic mice | Streptococcus pneumoniae | Increased expression, protection by both phosphorylcholine (PCh)-dependent and PCh-independent mechanisms | 33–38 | ||
CRP deficient mice | Streptococcus pneumoniae | protection by reconstitution with isolated pure human CRP, no role of the classical complement pathway | 39, 40 | ||
Rat | Schistosoma mansoni | Platelets treated with CRP were capable of conferring significant protection against schistosomiasis in transfer experiments | 41 | ||
Human | SARS-CoV-2 | Induces an uncontrolled auto- immune response and complement- and macrophage activation | 42, 43 | ||
Transgenic mouse and rabbit models | Neo-/autoantigens | Modified LDL | No effect, pro-atherogenic, anti-atherogenic | 44 | |
Human | Modified LDL | Pro- or anti-atherogenic? | 45 | ||
Apoptotic cells | Promotes noninflammatory clear- ance of apoptotic cells | 46 |
Taxon: systematic animal group; Species: representative example of the taxon; Antigen: abiotic or biotic (differential colored) triggers of innate (or adaptive) immunity; What is CRP doing?: alterations of expression levels and/or assumed function.